There was a clear trend towards tumor volume reduction after irradiation ( p = 0.05) (Figures 4B and 5A ) Tumor weight also decreased significantly after radiotherapy ( p < 0.05) (Figure 5B ).
← all phrases
“a clear trend”
Sighted at
p<0.09
In the literature
After the adjustment, a clear trend was observed ( p < 0.05) in which higher back extensor strength was associated with increased AMM (r = 1.12) and BMM (r = 0.89).
Although there is a clear trend towards increased cell viability in all cases, only Np-HSA-Mel showed statistically significant differences (non-parametric statistics, Kruskal–Wallis test, p < 0.05) compared to RDM, indicating that this kind of treatment may have a neuroprotective effect at the retinal level.
The OPLS-DA score plot showed a clear trend towards separation between the two groups, and the currently established discriminant model with R2Y cum = 0.366 ( P < 0.05) and Q2 cum = 0.129 ( P < 0.05) allowed for a valid distinction between the two samples, indicating that there were indeed metabolic differences between the case and control groups.
Our data showed no significant results on this issue (p = 0.0691) but a clear trend was observed for better LC with no stabilization or no Myelo-CT treatment planning (p = 0.0502).
In the CeL, a clear trend ( p = 0.0505, one-way ANOVA with Tukey’s posthoc tests) for increased GFAP (+) signals at chronic SNL compared to acute SNL was observed, but there were no statistically significant differences between the three groups ( Figure 1C , sham = 10, SNL 1w = 10, SNL 4w = 10 total GFAP (+) sample areas pe
Furthermore, stressed mice also presented a clear trend for a reduced inhibitory synaptic drive in D1-MSNs (Ctrl 17.047 ± 2.855, CS 10.444 ± 1.000; p = 0.0509) ( Fig. 3 f).
There was a clear trend for rheobase to be lower in females, but this was not at the level of statistical significance ( t (209) = 1.963, p = 0.0510) i ; delay to the first action potential (AP) ( t (209) = 0.2872, p = 0.7743) j and threshold ( t (209) = 0.6176, p = 0.5375) k did not differ by sex during pre-adolescence (Fig. 3 f–h).
1 C) and a clear trend in the correlation between DSC2 and disease-free interval (p = 0.051; Fig. 1 C).
Upregulated PGD2 levels positively correlated with 3 chemokines (IP10, MIP-1β, and RANTES) and the growth factor VEGF and had a clear trend to correlate with another chemokine MIP-1a ( p = 0.051).
3d ), with a clear trend visible also for Oscillospiracaee ( P = 0.052).
Patients initially treated with ICI sowed a clear trend towards longer post-DM-survival of 20.7 (95% CI: 13.9–27.6) vs 7.8 (95% CI: 4.4–11.5) months ( p = 0.052).
Patients were divided into three subgroups according to dynamic changes of EBV-DNA status: EBV-DNA persistently negative group (PNG, 24/58), EBV-DNA persistently positive group (PPG, 16/58), and EBV-DNA transformed from positive to negative group (TNG, 18/58); among the three groups, PPG had a clear trend toward worse PFS and OS ( P =0.0527 and P =0.0139, respectively) (Figure 1E, 1F).
hom p < 0.0001) and a clear trend toward the same effect in middle age, hom males (het vs. hom p = 0.0529).
Results A total number of 20 non-human immunodeficiency virus (HIV) patients with confirmed PJP and co-existing lung cancer were included in the current study, and classified into ICI group (n=9) and non-ICI group (n=11).There was a clear trend to a shorter onset of PJP in ICI group than non-ICI group (118.9 ± 60.9 vs 253.0 ± 185.1 days), although without statistical significance (p=0.053).
The rates for BARC type 3 to 5 and BARC type 2 to 5 bleeding were not statistically significantly different although BARC type 2 to 5 bleeding showed a clear trend towards more events in the PP-ZES arm (7.0 % vs. 2.9 %; p = 0.054).
However, in aged females, there was a clear trend for lower levels of acylcarnitines ( p = 0.054; Figure 3 B).
These modifications were associated with an improvement of liver stiffness which did not reach statistical significance but nonetheless marked a clear trend towards reduction (12.8 vs. 13.8 kPa, p = 0.055).
6e ); however, there were no significant differences in rate changes between genotypes, despite a clear trend for a slower rate in OsEPF1oeS (Kruskal–Wallis one‐way ANOVA, overall P = 0.056) (Fig. 6f ).
Just at 12 h after the introduction of the nestlet, rTg4510-treated mice were performing not significantly differently than controls, although there was a clear trend to show reduced nesting behavior ( p = 0.0569).
No changes were observed in the adrenal medulla; however, a clear trend of increased NE was observed in the kidney ( p = 0.0570).
resin) demonstrated a clear trend towards better hypertrophy (f = 3.833, p = 0.058).
The absolute collagen area in the plaque was reduced (−38.3%), and a clear trend toward a lower relative collagen content of the plaque (−23%; P =0.058) was demonstrated in the ONX-0914–treated group (Figure 1 C), indicating a less progressed plaque phenotype upon ONX-0914 treatment.
Of note, subgroup analysis of only patients that underwent mitral valve repair ( n = 76) showed a clear trend but not a statistically significant difference between LVEF decrease in BD versus FED (−5.7 ± 8.5% vs. −3.7 ± 7.1%, p = 0.059) ( Supplementary Table S1 ).
Despite a clear trend in the univariate analysis, high TLG (≥159.2 g) was not significantly correlated with poor OS (P=0.059).